// App-Quantinova.ai

: Biomarkers for Thrombosis in COVID-19: A Role for High Sensitivity Troponin-I and Immature Platelet Fraction?

Researchers

Presenter

  • Bilal Ashraf

Principal Investigators

  • Haekyung Jeon-Slaughter

  • Christopher Webb

  • Nicholas C.J. Lee

  • Weina Chen

  • Sung-Hee Choi

  • Taha Bat

  • Ibrahim F. Ibrahim

Medical Centers

  • UTSW MEDICAL CENTER, Dallas, TX

  • UT Southwestern Medical Center, Dallas, TX

  • Departments of Internal Medicine and Pediatrics, University of Texas Southwestern, Dallas, TX

  • Department of Internal Medicine, VA North Texas Health Care System, University of Texas Southwestern Medical Center,, Dallas

  • Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX

  • Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Infectious Diseases (ID)

Disease

  • Venous thrombosis

  • Coronavirus disease

Biomarkers

  • Troponin I

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved